Compare RPRX & IHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPRX | IHG |
|---|---|---|
| Founded | 1996 | 1777 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 21.4B |
| IPO Year | 2020 | 2000 |
| Metric | RPRX | IHG |
|---|---|---|
| Price | $54.87 | $167.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $51.40 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 211.1K |
| Earning Date | 05-06-2026 | 08-02-2016 |
| Dividend Yield | ★ 1.90% | 1.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.63 | $9.46 |
| Revenue Next Year | $4.73 | $5.51 |
| P/E Ratio | $82.49 | ★ $29.84 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $34.39 | $109.79 |
| 52 Week High | $56.50 | $165.63 |
| Indicator | RPRX | IHG |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 72.07 |
| Support Level | $35.35 | $133.08 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.31 | 3.02 |
| MACD | -0.15 | 0.40 |
| Stochastic Oscillator | 50.00 | 93.26 |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
InterContinental Hotels Group operates 1 million rooms across 20 brands addressing the midscale through luxury segments, as of Dec. 31, 2025. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023, followed by a premium conversion brand, Noted Collections, in 2026. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2025, the Americas represented 52% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 28%.